Literature DB >> 1521515

Rheumatologic and skeletal changes in acromegaly.

S A Lieberman1, A G Björkengren, A R Hoffman.   

Abstract

The anabolic functions of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in cartilage and bone metabolism are important in the normal physiology of these tissues. The effects of chronic elevation of GH and IGF-I levels on bony structures produce the typical physical changes associated with acromegaly, whereas the effects on cartilage result in arthropathy, which is usually degenerative. This article presents an overview of the physiologic roles of GH and IGF-I in cartilage and bone metabolism, the clinical features of the degenerative arthropathy and other rheumatologic syndromes associated with acromegaly, effects of acromegaly on bone and mineral metabolism, and an unusual bone disease that is occasionally associated with acromegaly, the McCune-Albright syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521515

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  18 in total

1.  Hand and foot abnormalities associated with genetic diseases.

Authors:  Henry J Mankin; Jesse Jupiter; Carol Ann Trahan
Journal:  Hand (N Y)       Date:  2010-10-26

Review 2.  Treatment options in acromegaly. Benefits and costs.

Authors:  L M Weekes; K K Ho; J P Seale
Journal:  Pharmacoeconomics       Date:  1996-11       Impact factor: 4.981

Review 3.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

4.  Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity.

Authors:  L M Fatti; B Cangiano; G Vitale; L Persani; G Mantovani; E Sala; M Arosio; P Maffei; F Dassie; M Mormando; A Giampietro; L Tanda; E R Masiello; E Nazzari; D Ferone; S Corbetta; E Passeri; F Guaraldi; S Grottoli; S Cannavò; M L T Torre; D Soranna; A Zambon; F Cavagnini; M Scacchi
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

Review 5.  Acromegaly: clinical features at diagnosis.

Authors:  Lucio Vilar; Clarice Freitas Vilar; Ruy Lyra; Raissa Lyra; Luciana A Naves
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

6.  The problem of unrecognized acromegaly: surgeries patients undergo prior to diagnosis of acromegaly.

Authors:  F E Keskin; D O Yetkin; H M Ozkaya; O Haliloglu; S Sadri; N Gazioglu; N Tanrıover; H Ak; E Hatipoglu; P Kadıoglu
Journal:  J Endocrinol Invest       Date:  2015-02-26       Impact factor: 4.256

Review 7.  Growth hormone in musculoskeletal pain states.

Authors:  Robert Bennett
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

8.  Ultrasonographic measurement of femoral cartilage thickness in acromegalic patients.

Authors:  Murat Karkucak; İbrahim Batmaz; Nadim Civan; Fatih Kilinc; Erhan Capkin; Mustafa Akif Sariyildiz; Melek Aslan Garipoğlu; Mustafa Avni Onder; Levent Ozcakar
Journal:  Clin Rheumatol       Date:  2014-02-27       Impact factor: 2.980

Review 9.  Acromegaly. Recognition and treatment.

Authors:  C A Jaffe; A L Barkan
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

10.  Functional evaluation of the joints in acromegalic patients and associated factors.

Authors:  Leandro Lemgruber Kropf; Miguel Madeira; Leonardo Vieira Neto; Mônica Roberto Gadelha; Maria Lucia Fleiuss de Farias
Journal:  Clin Rheumatol       Date:  2013-03-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.